Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Overall Survival of Patients With Unresectable HCC in Real-life
Sponsor: Humanity & Health Medical Group Limited
Summary
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in East Asia (more than 50% of the cases occurring in China). The aim of this study is to investigate the overall survival (OS) of patients diagnosed with unresectable hepatocellular carcinoma under real-world practice conditions in Asia Pacific region.
Official title: The Overall Survival of Patients Diagnosed With Unresectable Hepatocellular Carcinoma Under Real-life Clinical Practice in Asia Pacific Region
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2018-07-16
Completion Date
2025-12-31
Last Updated
2025-03-24
Healthy Volunteers
No
Conditions
Locations (3)
Beijing 302 Hospital
Beijing, China
Humanity & Health Medical Group Limited
Hong Kong, Hong Kong
Tokyo University
Tokyo, Japan